181 related articles for article (PubMed ID: 21762186)
1. Clinical features and natural history of hepatocellular adenomas: the impact of obesity.
Bunchorntavakul C; Bahirwani R; Drazek D; Soulen MC; Siegelman ES; Furth EE; Olthoff K; Shaked A; Reddy KR
Aliment Pharmacol Ther; 2011 Sep; 34(6):664-74. PubMed ID: 21762186
[TBL] [Abstract][Full Text] [Related]
2. [Transformation of hepatic adenoma into hepatocellular carcinoma in patients with prolonged use of oral contraceptives].
Herman P; Machado MA; Volpe P; Pugliese V; Vianna MR; Bacchella T; Machado MC; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1994; 49(1):30-3. PubMed ID: 8029613
[TBL] [Abstract][Full Text] [Related]
3. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.
Dokmak S; Paradis V; Vilgrain V; Sauvanet A; Farges O; Valla D; Bedossa P; Belghiti J
Gastroenterology; 2009 Nov; 137(5):1698-705. PubMed ID: 19664629
[TBL] [Abstract][Full Text] [Related]
4. Changing trends in malignant transformation of hepatocellular adenoma.
Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
[TBL] [Abstract][Full Text] [Related]
5. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
6. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization.
Stoot JH; van der Linden E; Terpstra OT; Schaapherder AF
Br J Surg; 2007 Oct; 94(10):1249-53. PubMed ID: 17696216
[TBL] [Abstract][Full Text] [Related]
7. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
Ott R; Hohenberger W
Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
[TBL] [Abstract][Full Text] [Related]
8. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy.
Deneve JL; Pawlik TM; Cunningham S; Clary B; Reddy S; Scoggins CR; Martin RC; D'Angelica M; Staley CA; Choti MA; Jarnagin WR; Schulick RD; Kooby DA
Ann Surg Oncol; 2009 Mar; 16(3):640-8. PubMed ID: 19130136
[TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
10. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
Othman M; Kawar B; El Nahas AM
Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.
Zucman-Rossi J; Jeannot E; Nhieu JT; Scoazec JY; Guettier C; Rebouissou S; Bacq Y; Leteurtre E; Paradis V; Michalak S; Wendum D; Chiche L; Fabre M; Mellottee L; Laurent C; Partensky C; Castaing D; Zafrani ES; Laurent-Puig P; Balabaud C; Bioulac-Sage P
Hepatology; 2006 Mar; 43(3):515-24. PubMed ID: 16496320
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
13. Hepatic adenomas: imaging and pathologic findings.
Grazioli L; Federle MP; Brancatelli G; Ichikawa T; Olivetti L; Blachar A
Radiographics; 2001; 21(4):877-92; discussion 892-4. PubMed ID: 11452062
[TBL] [Abstract][Full Text] [Related]
14. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience.
Erdogan D; Busch OR; van Delden OM; Ten Kate FJ; Gouma DJ; van Gulik TM
Liver Int; 2006 May; 26(4):433-8. PubMed ID: 16629646
[TBL] [Abstract][Full Text] [Related]
15. Management of ruptured hepatocellular adenoma.
Huurman VA; Schaapherder AF
Dig Surg; 2010; 27(1):56-60. PubMed ID: 20357452
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatocellular adenoma during pregnancy.
Noels JE; van Aalten SM; van der Windt DJ; Kok NF; de Man RA; Terkivatan T; Ijzermans JN
J Hepatol; 2011 Mar; 54(3):553-8. PubMed ID: 21094555
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular adenoma in 20 patients; recommendations for treatment].
de Wilt JH; de Man RA; Laméris JS; Zondervan PE; Tilanus HW; IJzermans JN
Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2459-63. PubMed ID: 10028326
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and therapeutic strategies in hepatocellular adenoma].
Weimann A; Fronhoff K; Gratz KF; Maschek H; Bartels M; Klempnauer J; Ringe B; Pichlmayr R
Zentralbl Chir; 1998; 123(2):140-4. PubMed ID: 9556886
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients.
Rhim H; Lim HK; Kim YS; Choi D
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e422-7. PubMed ID: 17944897
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
